LAURA NGUYEN: Open Payments
NPI 1033620828 · CLAYTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$911 in 39 payments from 15 companies in 2025. Trend: 2023 $814 · 2024 $650 · 2025 $911
Food & beverage: $905Education: $7
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $269 |
| Lilly USA, LLC | 8 | $198 |
| Novo Nordisk Inc | 5 | $105 |
| Bausch Health US, LLC | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Arcutis Biotherapeutics, Inc. | 2 | $38 |
| ABBVIE INC. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Kowa Pharmaceuticals America, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: Auvelity, MOUNJARO, Rybelsus, APLENZIN, ZORYVE, JARDIANCE, VRAYLAR, DUPIXENT.
Industry payments across NC — which companies pay providers there.
